A combination of two potential drugs gives hope of a ‘super blockage’ of an over-active immune system, Leiden researchers report in Nature. The breakthrough came from the crystallisation of a membrane protein.
Over-alert immune system
Our immune system is intended to protect the body against infiltrators. But sometimes it behaves too alertly, attacking the body itself. This results in chronic inflammation, such as multiple sclerosis, rheumatism or osteoarthritis.
Inhibiting inflammatory reactions
Laura Heitman, Ad IJzerman, Henk de Vries and Natalia Ortiz Zacarias from the Leiden Academic Centre for Drug Research (LACDR) are publishing their research this week in the journal Nature, research that may lead to a more effective way of inhibiting these responses. Their research focuses on the CCR2 receptor. The Leiden researchers work closely with an American team headed by Tracy Handel and Irina Kufureva.
Keyhole at nanoscale
A receptor is a kind of keyhole at nanoscale on the outside of a cell – in the cell membrane – into which a specific key molecule fits. The immune system comprises all kinds of immune cells, each with different types of receptors. The key molecules are called chemokines, and are produced by cells in diseased tissue. Immune cells are attracted automatically towards higher concentrations of chemokine, which generally means towards parts of the body where they are needed.
But patients with rheumatism or osteoarthritis produce too much CCL2, the chemokine for the CCR2 receptor. Although there are ways of blocking the CCR2 receptor, which in turn inhibits the inflammation, the inhibitors currently available prove to be largely ineffective in humans.
In order to discover how this process works at atomic level, Heitman and her colleagues examined the CCR2 protein using X-rays. This cannot be done using whole cells or a fragment of the cell membrane, where other proteins are also present. The researchers needed to have the CCR2 protein in very pure crystal form. This had never previously been done successfully. Laura Heitman: ‘If you take this kind of protein from the cell membrane, it’s very difficult to crystallise it.’
Thanks to this advance, researchers now have a detailed understanding of the three-dimensional form of the CCR2 protein, which is a good starting point for further research on the interaction beteween CCR2 and the related CCL2 chemokine.The research had immediate results: crystallisation was only possible if two inhibitors (BMS-681 and CCR2-RA-[R]) are both added to the CCR2 protein.
Possible duo medicine
Heitman: ‘This suggests a new strategy: duo therapy. By administering these two substances at the same time, you get a kind of “super blockage” of the CCR2 receptor, which is more effective than administering the two substances separately.’ Heitman refers to these substances deliberately as ‘potential medicines’: this is just the start of a process that could lead to a new duo medicine.
Heitman’s group will first continue their work with other receptors, CCR1 and CCR3 up to and including CCR9 before considering other super inhibitors. The ultimate aim is to manipulate the immune system so effectively that it only has beneficial effects, and the detrimental effects are excluded.
Learn more: Two-pronged attack on infectious diseases
[osd_subscribe categories=’immune-system-2′ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “IMMUNE SYSTEM”‘]
Receive an email update when we add a new IMMUNE SYSTEM article.
The Latest on: Overactive immune system
[google_news title=”” keyword=”overactive immune system” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Overactive immune system
- New mechanism discovered: B cells' contribution to immune tolerance in thymus glandon February 21, 2024 at 10:27 am
Immune cells must learn not to attack the body itself. A team of researchers from the Technical University of Munich (TUM) and the Ludwig Maximilian University of Munich (LMU) has discovered a ...
- How the additives in your vaccines rev up your immune systemon February 21, 2024 at 7:49 am
Using additives like aluminum in vaccines amps up their effectiveness, creating the right balance of inflammation to prevent disease.
- People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome May Have an “Exhausted” Immune Systemon February 20, 2024 at 4:00 pm
“The immune system in effect burns out ... Nath found some indirect evidence for autoimmunity. His team observed overactive B-cell genes in female ME/CFS participants. B cells are the source of ...
- New treatment for long Covid could be on the horizon, scientists sayon February 15, 2024 at 5:08 am
Researchers have found that long Covid may be caused by an overactive immune system, which could pave the way for new treatments for the condition ...
- Key discovery in long Covid treatment could lead to change in how we medicate for iton February 14, 2024 at 7:45 pm
According to the new study, an overreaction of the immune system that results in the body's circulation of inflammatory molecules may be the cause of chronic COVID-19. The study's identification of bi ...
- Biologics and JAK Inhibitors: What’s the Difference?on February 11, 2024 at 3:59 pm
Both of these medicines dampen an overactive immune system, which is your body’s defense system against germs. They help block the inflammation that can cause swelling, pain, and joint damage.
- New paper explains why females are prone to autoimmune diseaseson February 6, 2024 at 9:54 am
Eighty percent of patients with autoimmune diseases are female. These diseases are one of the top 10 leading causes of death for women under 65, and cases are increasing annually worldwide. There is ...
- Re-engineering Immune Cells Opens Door to Promising Therapy for Lupus Kidney Inflammationon February 5, 2024 at 6:30 pm
Dr. Ooi and colleagues re-engineered Tregs from SLE patients to specifically target the Smith protein, restoring their ability to suppress the overactive immune system. When tested in cells from ...
- "Zombie" COVID-19 fragments linger for some, causing severe disease outcomes, new research revealson February 2, 2024 at 7:02 am
There is a link between inflammation, the immune system and COVID-19 that is not ... and how it can sometimes lead to an overactive immune response. Yet the way in which this occurs remains ...
via Bing News